ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Carl Zeiss Meditec AG (PK)

Carl Zeiss Meditec AG (PK) (CZMWY)

63.58
0.00
(0.00%)
Closed March 11 3:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
63.58
Bid
67.09
Ask
67.27
Volume
-
0.00 Day's Range 0.00
46.1275 52 Week Range 134.598
Market Cap
Previous Close
63.58
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,830
Shares Outstanding
89,440,570
Dividend Yield
0.98%
PE Ratio
29.00
Earnings Per Share (EPS)
2
Revenue
2.07B
Net Profit
178.73M

About Carl Zeiss Meditec AG (PK)

Carl Zeiss Meditec is an integrated medical technology company with two main areas of business activity. Carl Zeiss Meditec is an integrated medical technology company with two main areas of business activity.

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
Headquarters
Jena, Deu
Founded
-
Carl Zeiss Meditec AG (PK) is listed in the Medical Laboratories sector of the OTCMarkets with ticker CZMWY. The last closing price for Carl Zeiss Meditec (PK) was US$63.58. Over the last year, Carl Zeiss Meditec (PK) shares have traded in a share price range of US$ 46.1275 to US$ 134.598.

Carl Zeiss Meditec (PK) currently has 89,440,570 shares outstanding. The market capitalization of Carl Zeiss Meditec (PK) is US$5.69 billion. Carl Zeiss Meditec (PK) has a price to earnings ratio (PE ratio) of 29.00.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.973.1975328680461.6170.13861.29287966.07344553DR
43.636.0550458715659.9570.13853.067551160.75480604DR
1213.5227.007590890950.0670.13846.1275983052.81269432DR
26-0.13-0.20404959974963.7180.091146.1275895257.75961864DR
52-66.575-51.1505512658130.155134.59846.1275683163.47810464DR
156-92.04-59.1440688857155.62171.146.1275475588.02379835DR
260-24.47-27.791027825188.05235.546.1275372895.34209857DR

CZMWY - Frequently Asked Questions (FAQ)

What is the current Carl Zeiss Meditec (PK) share price?
The current share price of Carl Zeiss Meditec (PK) is US$ 63.58
How many Carl Zeiss Meditec (PK) shares are in issue?
Carl Zeiss Meditec (PK) has 89,440,570 shares in issue
What is the market cap of Carl Zeiss Meditec (PK)?
The market capitalisation of Carl Zeiss Meditec (PK) is USD 5.69B
What is the 1 year trading range for Carl Zeiss Meditec (PK) share price?
Carl Zeiss Meditec (PK) has traded in the range of US$ 46.1275 to US$ 134.598 during the past year
What is the PE ratio of Carl Zeiss Meditec (PK)?
The price to earnings ratio of Carl Zeiss Meditec (PK) is 29
What is the cash to sales ratio of Carl Zeiss Meditec (PK)?
The cash to sales ratio of Carl Zeiss Meditec (PK) is 2.51
What is the reporting currency for Carl Zeiss Meditec (PK)?
Carl Zeiss Meditec (PK) reports financial results in EUR
What is the latest annual turnover for Carl Zeiss Meditec (PK)?
The latest annual turnover of Carl Zeiss Meditec (PK) is EUR 2.07B
What is the latest annual profit for Carl Zeiss Meditec (PK)?
The latest annual profit of Carl Zeiss Meditec (PK) is EUR 178.73M
What is the registered address of Carl Zeiss Meditec (PK)?
The registered address for Carl Zeiss Meditec (PK) is GOESCHWITZER STR. 51-52, JENA, 07745
What is the Carl Zeiss Meditec (PK) website address?
The website address for Carl Zeiss Meditec (PK) is www.zeiss.de
Which industry sector does Carl Zeiss Meditec (PK) operate in?
Carl Zeiss Meditec (PK) operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02215
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.015
(0.00%)
0
AABKFAareal Bank AG (CE)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.02215
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
DNZOFDenso Corp Ltd (PK)
US$ 12.56
(0.00%)
7.07M
CFGXCapital Financial Global Inc (CE)
US$ 0.000001
(0.00%)
2.5M
VGIDV Group Inc (CE)
US$ 0.000001
(0.00%)
2.5M
CSTFCuraScientific Corporation (CE)
US$ 0.000001
(0.00%)
1.38M
RYCEYRolls Royce Holdings PLC (PK)
US$ 9.81
(0.00%)
1.04M

Discussion

View Full Feed
ColdDarkHole ColdDarkHole 3 minutes ago
We missed WW3 by half a decade. Cant wait that long anymore. If only imminent actually meant imminent.
NB
scortech scortech 3 minutes ago
I know this is a broken record as well as a trading system,
2025-03-10 15,000,000 Short volume 30,435,000 total volume = 49.29% short volume
no one is selling 3's
Market Manipulators just trying to wipe out 3's with short (naked shares or borrowed) sold to bid and to have
CGAC
gorbec1 gorbec1 3 minutes ago
500 mil no it went from 50 mil to 500 mil now I know why we heard rumors of pos over a buck
MCIC
hopester hopester 3 minutes ago
At least in the pre-market the market is not impressed with the report.

Even though comparable comps on revenues and expenses improved, losses/sh to shareholders increased if you examine $$$ lost using the shares in the float for each period. Same for EBITA.
Factor that in, and
FCEL
Sammy boy Sammy boy 3 minutes ago
Arnold once again schooled you Tap Dancers!
FMCC
Hardazoak Hardazoak 4 minutes ago
100%
AABB
BlazingStocks BlazingStocks 4 minutes ago
$COEP News March 11, 2025
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
https://finance.yahoo.com/news/coeptis-therapeutics-secures-worldwid
COEP
TechandBio TechandBio 4 minutes ago
The key data point for SGMT Nash phase 3's 3100+ patients is that the Data is spectacularly better than MGDL THR Beta and the problem with Akero drug is that is causes reductions in bone mineral density were observed for the EFX dose were 43%
New CFO Sagimet Biosciences Appointment of Thie
AKRO MDGL SGMT
royal1 royal1 4 minutes ago
Bashers can't sleep at night. Wonder what they are worried about? Certainly not us loosing our investments...
HMBL
art2426 art2426 4 minutes ago
You can repeat that everyday, all day, it is not convincing anyone to 'BUY' as reflected in this seriously low triple zero stock price and pathetic volume, as yesterday's 710,000 shares of $170 showed. No interest in a stock, is never a good sign. No communication from the CEO of a continuous losing
BIEL
boston127 boston127 4 minutes ago
Good luck! The market downturn

will end soon, as there is a ton of $$$ waiting to be invested.
IGPK
marcis marcis 5 minutes ago
Thanks JC, 🙏 RDAR Shell Risk removed yesterday.
Wasn’t this a major point last week for not buying.
Because the merger wasn’t consummated?

There is obviously a large naked short position here still, from before the Mexedia took over of RDAR. from the old owners
HMBL RDAR
Fallingknife75 Fallingknife75 5 minutes ago
Nice PR. It gives good insight into the next phase of the company's development.

All the best,

Knife
HYSR
RIGATONI RIGATONI 5 minutes ago
Nice news here..

BTTR $1.68 news...

Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence

https://www.globenewswire.com/news-release/2025/03/11/3040686/0/en/Better-Choice-Company-Signs-Binding
BTTR
resx18 resx18 5 minutes ago
$CBDW looking to transform the Waste Management industry using their AI technologies - huge news out this AM!

https://www.wjbf.com/business/press-releases/accesswire/997323/1606-corp-signs-loi-to-be-acquired-by-private-group-seeking-to-enter-the-public-markets-and-utilize-ai-technolog
CBDW
PEACHMAN PEACHMAN 6 minutes ago
IFUS tweet yesterday may be followed up with a pr to provide transparency as to the next steps toward potential Joint Venture in India.

https://x.com/ImpactfusionI/status/1899135976003293390?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet


IFUS STRONG
IFUS
sirant sirant 6 minutes ago
Multicorp International, Inc. style="font-family: inherit; line-height: 1.5em; font-size: 0.8em; margin-left: 2em; font-weight: normal; color: rgba(147, 149, 151, 1)"Press Release | 03/11/2025
MCIC
nssrr5 nssrr5 6 minutes ago
LMAO he is spot on - the orange man has crushed this market and it will not recover any time soon. There is another 15 to 20 percent to the down side coming. Sad but true...
TLRY
sirant sirant 7 minutes ago
Multicorp International, Inc. style="font-family: inherit; line-height: 1.5em; font-size: 0.8em; margin-left: 2em; font-weight: normal; color: rgba(147, 149, 151, 1)"Press Release | 03/11/2025
MCIC
xoom xoom 7 minutes ago
LG, with Bop’s potential $360K per P, Pliss makes a potential $251,640,000 for Pliss’s 699 P’s.
COOP
ctkrod ctkrod 7 minutes ago
Trump does not plan in the order to establish a U.S. critical minerals stockpile that would mimic the Strategic Petroleum Reserve, the sources said, a step that some in the administration and mining industry had sought.... Trump also does not plan to order the Pentagon or other U.S. agencies to requ
NB
prophet2 prophet2 7 minutes ago
So Ham what day is the news release suppose to come? I was hoping today but doesn't look likely now. the prophet
VPLM
stockprofitter stockprofitter 8 minutes ago
$20.00 IN MARCH
FNMA
mattymatt66 mattymatt66 8 minutes ago
Beyond head scratching how there are 20mm shares short at $1.12 SP. upside is minimal, downside is enormous. I just don't get it. 
LWLG

Your Recent History

Delayed Upgrade Clock